P
Peter Simmonds
Researcher at University of Oxford
Publications - 857
Citations - 69113
Peter Simmonds is an academic researcher from University of Oxford. The author has contributed to research in topics: Hepatitis C virus & Virus. The author has an hindex of 131, co-authored 823 publications receiving 62953 citations. Previous affiliations of Peter Simmonds include John Radcliffe Hospital & Edinburgh Royal Infirmary.
Papers
More filters
Journal ArticleDOI
The circadian clock components BMAL1 and REV-ERBα regulate flavivirus replication.
Xiaodong Zhuang,Andrea Magri,Michelle L. Hill,Alvina G. Lai,Abhinav Kumar,Srinivasa Bhargav Rambhatla,Claire L. Donald,Andrea F. Lopez-Clavijo,Simon A. Rudge,Katherine E. Pinnick,Wai Hoong Chang,Peter A C Wing,Ryan M. Brown,Ximing Qin,Peter Simmonds,Thomas F. Baumert,David W. Ray,Andrew S. I. Loudon,Peter Balfe,Michael J.O. Wakelam,Sam Butterworth,Alain Kohl,Catherine L. Jopling,Nicole Zitzmann,Jane A. McKeating +24 more
TL;DR: A role for the circadian clock component REV-ERBα in regulating flavivirus replication is highlighted, as it affects entry of hepatitis C virus into hepatocytes and genome replication of HCV and related flaviviruses dengue and zika.
Journal ArticleDOI
Global trends and emission estimates of CCl4 from in situ background observations from July 1978 to June 1996
Peter Simmonds,Derek M. Cunnold,Ray F. Weiss,Ronald G. Prinn,Paul J. Fraser,Archie McCulloch,F. N. Alyea,Simon O'Doherty +7 more
TL;DR: In this article, the Scripps Institution of Oceanography (SIO) 1993 absolute calibration scale is used, reducing the concentrations by a factor of 0.77 compared to previous ALE/GAGE reports.
Journal ArticleDOI
Clinical relevance of hepatitis C virus genotypes
TL;DR: Genotypes ofHCV Hepatitis C virus (HCV) has been identified as the main causative agent of post-transfusion non-A, non-B hepatitis, and recent analyses indicate that the current genotypes of HCV evolved from a common ancestor at least 500-2000 years ago.
Journal ArticleDOI
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.
Craig Thompson,Nicholas Grayson,Robert S. Paton,Jai S Bolton,José Lourenço,Bridget S. Penman,Lian Ni Lee,Valerie Odon,Juthathip Mongkolsapaya,Senthil Chinnakannan,Wanwisa Dejnirattisai,Matthew Edmans,Alex Fyfe,Carol Imlach,Kreepa Kooblall,Nicholas T.Y. Lim,Chang Liu,Cesar Lopez-Camacho,Carol McInally,Anna L McNaughton,Narayan Ramamurthy,Jeremy Ratcliff,Piyada Supasa,Oliver Sampson,Beibei Wang,Alexander J. Mentzer,Marc Turner,Malcolm G Semple,Kenneth Baillie,Heli Harvala,Gavin R. Screaton,Nigel J. Temperton,Paul Klenerman,Lisa Jarvis,Sunetra Gupta,Peter Simmonds +35 more
TL;DR: Although blood donors are not representative of the overall population, it is demonstrated that serosurveys of blood banks can serve as a useful tool for tracking the emergence and progression of an epidemic such as the SARS-CoV-2 outbreak.
Journal ArticleDOI
Clinical perspectives of emerging pathogens in bleeding disorders
Christopher A. Ludlam,William G. Powderly,Samuel A. Bozzette,Michael P. Diamond,Marion A. Koerper,Roshni Kulkarni,Bruce Ritchie,Jamie E. Siegel,Peter Simmonds,Samuel L. Stanley,Michael L. Tapper,Mario von Depka +11 more
TL;DR: Plasma-derived CFC are now judged safe in terms of many known infectious agents, including hepatitis B and C viruses, HIV, and human T-cell lymphotropic virus, but emerging pathogens could pose future threats, particularly those with blood-borne stages that are resistant to viral-inactivation steps in the manufacturing process, such as non-lipid-coated viruses.